Dj%25252525252525252525252520citral

# Citral ## Overview Citral is an acyclic monoterpene aldehyde ($C_{10}H_{16}O$) commonly found in essential oils (e.g., lemongrass, lemon peel). While it lacks widespread status as a conventional pharmaceutical drug, it is utilized as a flavoring agent, fragrance component, and in investigational naturopathic or homeopathic contexts. It is not currently FDA-approved for the treatment of specific medical conditions. ## Primary Indications There are no established, evidence-based clinical indications for citral. It is periodically investigated for: * Antimicrobial and antifungal topical applications. * Antioxidant or anti-inflammatory research. * Use as a permeation enhancer for transdermal drug delivery. ## Adult Dosing No established therapeutic dose exists. Dosing is highly variable based on intended use (e.g., flavoring vs. experimental research). In food applications, it is Generally Recognized as Safe (GRAS) by the FDA, but therapeutic systemic dosing has not been defined in clinical trials. ## Pediatric Dosing No established pediatric dose. Due to the high risk of contact dermatitis and potential respiratory irritation, it is not recommended for pediatric use. ## Dose Adjustments There are no clinical guidelines for hepatic or renal dose adjustments as there is no standardized clinical dosing. ## Contraindications * **Hypersensitivity:** Known allergy to citral or products containing high concentrations of essential oils. * **Dermatological:** Avoid use on broken or inflamed skin due to high risk of sensitization. ## Adverse Effects * **Dermatological:** High risk of contact dermatitis; frequent skin sensitizer. * **Ocular/Respiratory:** Potential for ocular irritation and respiratory sensitization if inhaled in concentrated forms. * **Systemic:** High-dose ingestion in animal models has occasionally shown evidence of endocrine or cellular toxicity. ## Key Drug Interactions Information is limited. However, as a potential inducer or inhibitor of cytochrome P450 enzymes (specifically CYP2B6/3A4 in in vitro models), caution is advised if used concurrently with drugs having a narrow therapeutic index. ## Monitoring Not applicable in clinical practice. If used in a research setting, monitor for signs of skin sensitization, allergic reaction, or evidence of hepatotoxicity. ## Clinical Pearls * **Sensitization:** Citral is recognized as a potent fragrance allergen. Standardized patch testing suggests a threshold for skin reactivity; always perform a patch test before topical application. * **Stability:** Highly unstable in light and oxygen; it prone to oxidation, which increases the likelihood of allergic contact dermatitis. * **Regulatory:** FDA approval is strictly as a flavoring agent, not a therapeutic agent. Any claims regarding anti-cancer or anti-inflammatory effects remain strictly investigational. *** **Educational Disclaimer:** This information is for educational purposes only. Citral is not an FDA-approved drug for treating medical conditions. Dosing and safety profiles are not clinically established. Always verify current prescribing information, institutional protocols, and regulatory status through primary sources (e.g., FDA labels, Micromedex, or Clinical Pharmacology) before use.